Evidence map›Paper›PMID 32953360›Full record

ArticleCureus2020

Suicide Attempt in a 38-Year-Old Patient on Varenicline While Intoxicated With Alcohol.

Ismet Yesilada, Edward Bach, Luba Leontieva

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ismet YesiladaPsychiatry, State University of New York Upstate Medical University, Syracuse, USA.
Edward BachPsychiatry, State University of New York Upstate Medical University, Syracuse, USA.
Luba LeontievaPsychiatry, State University of New York Upstate Medical University, Syracuse, USA.
SUNY Upstate Medical University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Varenicline is one of two non-nicotine replacement therapy medications approved by the FDA for smoking cessation. It has also demonstrated some success in trials for the treatment of alcohol use disorder. In this case report, we present a case of a 38-year-old male with a history of alcohol and tobacco use disorders and no other psychiatric history, including no history of suicidal ideation or suicide attempts, who was admitted to an inpatient psychiatric facility after a suicide attempt while acutely intoxicated with alcohol one week after starting varenicline treatment for smoking cessation. Reports from the media, and literature from the FDA and manufacturers of CHANTIX

Indexed as

alcoholamnesiablackoutchantixintoxicationsmokingsmoking cessationsuicidal behaviorsuicidevarenicline

Identifiers

PMID32953360
PMCPMC7495681
OpenAlexW3085003840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.